JACC Podcast podcast

1-Year Results of ADVANTAGE AF | JACC Deep Dive

2025-04-29
0:00
7:28
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

In this JACC Deep Dive episode, Dr. Harlan Krumholz reviews the ADVANTAGE-AF trial, which evaluated pulse field ablation (PFA) as a treatment for persistent atrial fibrillation. The study demonstrated that PFA is a safe and effective approach, with strong symptomatic outcomes and a low complication rate, though questions remain about long-term durability and the need for more rigorous follow-up. PFA represents a promising innovation, but further randomized studies and extended monitoring will be essential to fully define its role in clinical practice.

Fler avsnitt från "JACC Podcast"